SOURCE-LINKED INTELLIGENCE

PREDICTION OF ALZHEIMER’S DISEASE USING AN AI DRIVEN SCREENING PLATFORM

CORDIS · observation · Publication date unknown

ysis. We will also evaluate innovative technologies for disease risk identification, including digital technologies and novel MRI, EEG, eye tracking, and blood-based biomarkers. The platform will use artificial intelligence models to analyse data from all biomarkers to identify users at high risk of developing dementia and to direct them to personalized intervention to prevent further cognitive decline and development of dementia. We will seek to facilitate a change in current healthcare practice for early diagnosis of AD through development of new clinical practice guidelines based on evidence generated in the project. By improving the ease of identification of those with early signs of dementia we expect to have a significant impact on personal and financial burden of dementia in Europe and across the world. Alzheimer’s disease; dementia; biomarker accessibility; digital biomarkers; artificial intelligence; blood-based biomarkers; MRI; EEG; platform; screening

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

8449326.38

unit

EUR